More from Tar ⚡
Case Study: Bharat Electronics Ltd
OPM: 23%
Free Float: <5%
QoQ continuous increase in ownership by institutions
ROE: ~20%
ROCE: ~28%
EV by EBITDA: 15
Leading developer of Indigenous Military Drones
Exports are prime focus for the company
D: Invested, not a recommendation
OPM: 23%
Free Float: <5%
QoQ continuous increase in ownership by institutions
ROE: ~20%
ROCE: ~28%
EV by EBITDA: 15
Leading developer of Indigenous Military Drones
Exports are prime focus for the company
D: Invested, not a recommendation
Lots of under owned stocks with robust financials within Defense Sector \U0001fa96\U0001f396\ufe0f
— Tar \u26a1 (@itsTarH) April 12, 2022
You don't even have to try looking very hard to find something interesting
120: It's just a power exchange
250: Electricity in India won't grow
300: It just makes 4paise per trade
350: MBED will erode it's profitablilty
500: Maybe what @itsTarH said about IEX = NSE + Zerodha was right
570: Buys IEX
#JourneyOfAPessimist
250: Electricity in India won't grow
300: It just makes 4paise per trade
350: MBED will erode it's profitablilty
500: Maybe what @itsTarH said about IEX = NSE + Zerodha was right
570: Buys IEX
#JourneyOfAPessimist
Zerodha + NSE = IEX \U0001f4a1\u26a1\ufe0f
— Tar \u26a1 (@itsTarH) June 20, 2021
More from Iex
#iex look how it reached the yellow line #hporb
closing above 428 would be swell https://t.co/uZj5paFe6Q
closing above 428 would be swell https://t.co/uZj5paFe6Q
from the analysis done few sessions ago for #iex Indian energy Exchange till now #hporb https://t.co/LnqCcCjxqq pic.twitter.com/tMcubrT6JP
— RB\U0001f4ab The Trend Trader (@usb_3Dot0) August 15, 2021
To see the bull case for #IEX one needs a bit of imagination on their side :)
Market always moves to the cheaper alternative, slowly at first, then all of a sudden.
Market always moves to the cheaper alternative, slowly at first, then all of a sudden.
As more and more companies look towards the ESG factors, IEX would be a potential beneficiary.
— Kharanshu Parikh (@Kharanshu) August 7, 2021
Source: Suven Pharma\u2019s Annual Report
\u2066@itsTarH\u2069 pic.twitter.com/sRdMIAMaVP